PRKN and cancer: PARK2, a prominent RING family E3 ubiquitin ligase, promotes polyubiquitination degradation of the K48 link of YAP in ESCC cancer cells [191] and JOSD2 stabilizes YAP/TAZ by cutting polyubiquitin chains, thus enhancing hippo signal transduction [192].